Sinha, Sanju
Sinha, Neelam
Perales, Marlenne
Tarrab, Adi
Nguyen, Trinh
Liu, Lihe
Cantore, Thomas
Alvarez, Kyle
Patiyal, Sumeet
Mukherjee, Sumit
Madan, Sanna
Tharp, Kevin
Zhao, Jianhua
Kumar, Ranjit
Flanigan, Greg
Beutler, John A.
O’Keefe, Barry R.
Meerzaman, Daoud
Ben-David, Uri
Deshpande, Aniruddha J.
Ruppin, Eytan
Article History
Received: 17 December 2024
Accepted: 5 September 2025
First Online: 5 November 2025
Competing interests
: Authors Eytan Ruppin (E.R) and Sanju Sinha are the inventors on a pending provisional patent application related to the DeepTarget algorithm. E.R. is a co-founder of Medaware, Metabomed, and Pangea Therapeutics (divested from the latter). E.R. is a non-paid scientific consultant to Pangea Therapeutics, a company developing a precision oncology SL-based multi-omics approach. The rest of the authors declare no conflict of interest.